Green Valley Investors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-289,546
Closed -$20.5M 34
2018
Q2
$20.5M Sell
289,546
-20,335
-7% -$1.44M 0.96% 30
2018
Q1
$23.4M Buy
309,881
+99,800
+48% +$7.93M 1.11% 27
2017
Q4
$15.1M Sell
210,081
-16,624
-7% -$1.26M 0.72% 28
2017
Q3
$18.4M Sell
226,705
-6,850
-3% -$524K 0.9% 28
2017
Q2
$16.5M Sell
233,555
-152,897
-40% -$10.2M 0.81% 27
2017
Q1
$26.2M Sell
386,452
-399,476
-51% -$28.1M 1.29% 24
2016
Q4
$56.3M Sell
785,928
-20,722
-3% -$1.54M 2.95% 13
2016
Q3
$63.8M Sell
806,650
-967,898
-55% -$78.6M 3.27% 11
2016
Q2
$148M Sell
1,774,548
-712,728
-29% -$63.3M 4.53% 9
2016
Q1
$228M Sell
2,487,276
-512,724
-17% -$46.2M 5.59% 6
2015
Q4
$304M Hold
3,000,000
6.23% 4
2015
Q3
$295M Hold
3,000,000
6.32% 4
2015
Q2
$351M Hold
3,000,000
6.76% 4
2015
Q1
$294M Buy
3,000,000
+500,000
+20% +$50.8M 5.91% 4
2014
Q4
$236M Hold
2,500,000
4.96% 5
2014
Q3
$266M Hold
2,500,000
6.08% 4
2014
Q2
$207M Buy
2,500,000
+1,300,000
+108% +$101M 4.82% 5
2014
Q1
$85M Hold
1,200,000
1.95% 21
2013
Q4
$90.1M Buy
+1,200,000
New +$83.6M 1.97% 22

Other funds holding GILD

Green Valley Investors's GILD Position: Q3 2018 in Review

Green Valley Investors sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 289,546 shares — an estimated $20.5M sold.

Green Valley Investors first reported a position in GILD in Q4 2013 and held it in 19 quarters. The position peaked at $351M in Q2 2015. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.

  • Green Valley Investors reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
  • Green Valley Investors sold 289,546 Gilead Sciences shares in Q3 2018, an estimated $20.5M.
  • Green Valley Investors first reported a position in Gilead Sciences in Q4 2013 and held it in 19 quarters.
  • Green Valley Investors's Gilead Sciences position peaked at $351M in Q2 2015.
  • 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.

Based on Green Valley Investors's 13F filing for Q3 2018, filed 13 Nov 2018.